AAM
DNA icon

Advisors Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Advisors Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-284
Closed -$3.8K – 1479
2024
Q2 		$3.8K Sell
284
-97
-25% -$2.89K ﹤0.01% 1434
2024
Q1 		$17.7K Sell
381
-52
-12% -$2.69K ﹤0.01% 1370
2023
Q4 		$29.2K Sell
433
-8
-2% -$490 ﹤0.01% 1332
2023
Q3 		$32K Buy
441
+30
+7% +$2.4K ﹤0.01% 1323
2023
Q2 		$30.6K Buy
411
+289
+237% +$17.1K ﹤0.01% 1336
2023
Q1 		$6.5K Buy
122
+78
+177% +$4.94K ﹤0.01% 1433
2022
Q4 		$2.96K Buy
+44
New +$4.05K ﹤0.01% 1472

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Advisors Asset Management's DNA Position: Q3 2024 in Review

Advisors Asset Management sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 284 shares — an estimated $3.8K sold.

Advisors Asset Management first reported a position in DNA in Q4 2022 and held it in 7 quarters. The position peaked at $32K in Q3 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Advisors Asset Management reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Advisors Asset Management sold 284 Ginkgo Bioworks shares in Q3 2024, an estimated $3.8K.
  • Advisors Asset Management first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 7 quarters.
  • Advisors Asset Management's Ginkgo Bioworks position peaked at $32K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Advisors Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.